News & Analysis on Clinical Trial Services & Contract Research And Development
Sensyne Health: Sensight RWD analytics platform
By Jenni Spinner
- Last updated on
Artificial intelligence firm Sensyne Health has introduced the Sensight artificial intelligence data analytics platform for healthcare and life science applications. It is designed to provide industrial-scale access to de-identified real-world data (RWD) insights across multiple therapy areas, with built-in research algorithms, to help accelerate drug discovery.
Sensyne CEO Paul Drayson said, “The transformative power of Sensyne’s ethical AI is now available to the smallest and largest healthcare and life sciences organizations and its design enables the creation of a global community of researchers all working towards a common aim: better health for all.”